Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business1 February 2016Corporate and M&A Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categorySkadden and Paul Weiss lead as Intel buys back $14bn Apollo stake in Irish semiconductor plantBigger than eBay and News Corp: running the data on Kirkland’s staggering scaleS&C, Kirkland, Skadden among Q1 M&A leaders as megadeals drive activitySkadden and Paul Weiss lead as Intel buys back $14bn Apollo stake in Irish semiconductor plantSpread of transatlantic firms in the mix on Unilever’s $45bn food business sale‘The merger is working’ – HSF Kramer on its US corporate pushRevolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesFive partners vie to succeed Hoyland as Simmons managing partner‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetry